Atlas Trials

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy Subjects

Clinical trial NCT07001787 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07001787
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2025-06-01
Primary completion
2026-02-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.